CD274 and neoplasm: In addition, based on the combination therapy of inhibiting LSD1 and blocking PD-(L)1, further inhibition of tumor growth-promoting cytokines (e.g.TGF-β) induced by LSD1 inhibition could potentially improve the effectiveness of combination therapy for poorly immunogenic tumors.